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Artemisinin, a sesquiterpene lactone produced by Artemisia annua glandular secretory
trichomes, is the active ingredient in the most effective treatment for uncomplicated
malaria caused by Plasmodium falciparum parasites. Other metabolites in A. annua or
related species, particularly flavonoids, have been proposed to either act as antimalarials
on their own or act synergistically with artemisinin to enhance antimalarial activity.
We identified a mutation that disrupts the CHALCONE ISOMERASE 1 (CHI1) enzyme
that is responsible for the second committed step of flavonoid biosynthesis. Detailed
metabolite profiling revealed that chi1-1 lacks all major flavonoids but produces wild-
type artemisinin levels, making this mutant a useful tool to test the antiplasmodial
effects of flavonoids. We used whole-leaf extracts from chi1-1 and mutant lines
impaired in artemisinin production in bioactivity in vitro assays against intraerythrocytic
P. falciparum Dd2. We found that chi1-1 extracts did not differ from wild-type extracts in
antiplasmodial efficacy nor initial rate of cytocidal action. Furthermore, extracts from the
A. annua cyp71av1-1 mutant and RNAi lines impaired in amorpha-4,11-diene synthase
gene expression, which are both severely compromised in artemisinin biosynthesis but
unaffected in flavonoid metabolism, showed very low or no antiplasmodial activity. These
results demonstrate that in vitro bioactivity against P. falciparum of flavonoids is negligible
when compared to that of artemisinin.
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INTRODUCTION
Malaria is one of the most prevalent infectious diseases with 219 million cases and 435,000 deaths
reported in 2017 (World Health Organization [WHO], 2018). The WHO recommends the use of
artemisinin-based combination therapies (ACTs) for treatment of uncomplicated malaria caused
by the Plasmodium falciparum parasite (World Health Organization [WHO], 2018). ACTs consist
of fast-acting and stable artemisinin derivatives, such as artesunate, co-formulated with a different
class of drug to reduce the emergence of resistance and increase treatment efficacy (Petersen et al.,
2011). The main source of the sesquiterpene artemisinin is currently the medicinal plant Artemisia
annua, which has achieved a yield of 1.5% dry leaf weight through breeding (Townsend et al., 2013).
Additionally, a semi-synthetic alternative has been developed through precursor biosynthesis in
yeast and chemical conversion to artemisinin (Peplow, 2016).
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Artemisia annua accumulates artemisinin together with a wide
range of secondary metabolites in the extracellular subapical
cavity of glandular secretory trichomes, specialized 10-cell
structures on the surfaces of aerial tissues (Brown, 2010; Lange,
2015; Czechowski et al., 2018). This wide range of metabolites has
led to speculation that perhaps other compounds in A. annua or
related species might act as antimalarials or potentially enhance
the antimalarial activity of artemisinin. Therefore, several groups
have tried to isolate and identify metabolites from A. annua and
related species that might function as antimalarials (O’Neill et al.,
1985; Elford et al., 1987; Liu et al., 1989, 1992; Cubukcu et al.,
1990; Mueller et al., 2000; Bhakuni et al., 2001; Kraft et al., 2003).
Recent publications have reported that A. annua whole-
plant preparations are more effective than artemisinin alone
(not ACTs) in treating rodent malaria (Elfawal et al., 2012)
and reducing the development of resistance (Elfawal et al.,
2015), and that whole-plant preparations may be effective in
treating artesunate-resistant malaria patients (Daddy et al.,
2017). These results suggest that A. annua produces metabolites
that might act together with artemisinin and thus whole-plant
preparations have been proposed as replacement treatments for
ACTs (Weathers et al., 2014). In particular, flavonoids have been
singled out as the likely synergistic metabolites (Elfawal et al.,
2012, 2015; Weathers et al., 2014; Daddy et al., 2017) mainly
because there is some evidence that they may improve the
antimalarial activity of artemisinin in vitro (Elford et al., 1987;
Liu et al., 1989, 1992; Ferreira et al., 2010).
Flavonoids are a diverse class of plant and fungal secondary
metabolites with over 6500 different flavonoid products described
from the secondary metabolism of various plant species
(Ververidis et al., 2007). Flavonoid biosynthesis starts from
primary metabolism precursors: phenylalanine and malonyl-
CoA. Phenylalanine is used to produce 4-coumaroyl-CoA which
is then combined with malonyl-CoA by chalcone synthase to
yield the two-phenyl ring backbone common to all chalcones.
A key step in flavonoid synthesis is the conjugate ring-closure
of chalcones catalyzed by chalcone-flavanone isomerase (CHI),
which results in the three-ringed structure of a flavone. The
phenylpropanoid metabolic pathway contributes a series of
enzymatic modifications that yield flavanones, dihydroflavonols,
and eventually anthocyanins. Many products can be derived from
this pathway including flavonols, flavan-3-ols, proanthocyanidins
(tannins) and a host of other various polyphenolics (Ververidis
et al., 2007). Flavonoids have been classified according to
the position of the linkage of the aromatic ring to the
benzopyrano moiety into four classes: major flavonoids (2-phenyl
benzopyrans), which include flavonols, flavonones, flavanonols,
flavones, anthocyanins and anthocyanidines; isoflavonoids (3-
benzopyrans), which contain isoflavanons, isoflavanones and
isoflavanonols; neo-flavonoids (4-benzopyrans) which include
neoflavenes and 4-arylcoumarins; and finally, minor flavonoids
which include aurones, auronols, 2′OH chalcones and 2′OH
dihydrochalcones (Ververidis et al., 2007).
In the present work we report an A. annua loss-of-function
mutation of the trichome-specific CHALCONE ISOMERASE 1
(CHI1) gene. Levels of all major flavonoids in the chi1-1 mutant
were reduced to undetectable levels. We used chi1-1 to test the
antimalarial effects of flavonoids. We extended the bioassays to
include whole-leaf extracts from A. annua silenced in amorpha-
4,11-diene synthase (AMS), which encodes the enzyme that
catalyzes the first committed step of artemisinin biosynthesis
(Catania et al., 2018), and the cyp71av1-1 mutant, impaired
in the second committed step of artemisinin biosynthesis
(Czechowski et al., 2016). The AMS silenced line has dramatically
reduced artemisinin production (5% of the wild-type levels) and
accumulates the sesquiterpene precursor farnesyl pyrophosphate
in trichomes (Catania et al., 2018). cyp71av1-1 completely
abolishes artemisinin production and redirects the artemisinin
pathway to the synthesis of arteannuin X, a novel sesquiterpene
epoxide (Czechowski et al., 2016). Both the AMS silenced and
cyp71av1-1 mutant lines produce wild-type levels of major
flavonoids. We have performed a comparative analysis of whole-
leaf extracts from chi1-1, the AMS silenced line, cyp71av1-1, and
wild-type A. annua in in vitro P. falciparum Dd2 kill assays (Ullah
et al., 2017) to determine the antiplasmodial efficacy and initial
cytocidal activity of these extracts.
MATERIALS AND METHODS
Plant Material
For wild-type plant material we used the Artemis F1 hybrid
variety of A. annua developed by Mediplant (Conthey,
Switzerland), obtained by crossing C4 and C1 parental lines of
East Asia origin (Delabays et al., 2001). Seeds were sown in
4-inch pots filled with Levington modular compost and grown
in a glasshouse under long-day conditions (16-h day/8-h night)
at 17–22◦C for 12 weeks.
RNA Isolation and Semi-Quantitative
RT-PCR
Total RNA was isolated from eight A. annua tissues: meristems,
cotyledons, trichomes, young leaves, expanded leaves, mature
leaves, stems, and flowers as previously described (Graham et al.,
2010) and quantified using the NanoDrop 8000 (NanoDrop
products, Wilmington, DE, United States). 5 µg of total
RNA was digested with RQ1 RNase-free DNase (Promega,
United Kingdom) according to the manufacturer’s protocol. 1st
strand cDNA synthesis was performed using 2.5 µg of DNaseI
digested RNA with oligo dT(18) primers and SuperScriptTM
II Reverse Transcriptase (Thermo Fisher, United Kingdom)
according to manufacturer’s protocols. 3 µL of the first strand
cDNA was used for PCR amplification using the following gene
specific primers: CHI1_For: 5′-TGGCAACACCACCTTCAGC
TACC-3′ (left), CHI1_Rev: 5′-GTTGTGAAGAGAATAGAG
GCG-3′ (right), CHI2_For: 5′-ATGGCTAAGCTTCATTCCTCC
AC-3′ (left), CHI2_Rev: 5′-CAGGTATGATACCATCTCTA
GC-3′ (right), CHI3_For 5′-CTGGAGCAATTCCCAGATC
AG-3′ (left), CHI3_Rev 5′-AGAATGTTTTGCCATCAACATC
TC-3′ (right), Ubiquitn_For: 5′-GTCGGCTAATGGAGAAG
ACAAGAAG-3′ (left) and Ubiquitn_Rev: 5′-GAAAGCA
CGACCAGATTCATAGC-3′ (right) using GoTaqTM Taq
polymerase (Promega, United Kingdom). The PCR program
used to amplify the target sequences was: 94◦C, 2 min; followed
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by 10 cycles of “touch down”: 94◦C, 30 sec; 65◦C (−1◦C/cycle);
72◦C, 1 min, followed by 20 cycles of 94◦C, 30 sec; 55◦C, 30 sec;
72◦C, 1 min, followed by a final extension at 72◦C for 5 min.
10 µL of PCR product was resolved on 1% agarose gels. Predicted
product sizes for each gene are: 466 bp for CHI1, 520 bp for
CHI2, 507 bp for CHI3, and 454 bp for UBQ.
chi1-1 Mutant Isolation and
Characterization
An ethyl methanesulfonate-mutagenized A. annua population
was established as described before (Graham et al., 2010;
Czechowski et al., 2016). Screening of the self-fertilized M2
population was performed as previously described (Czechowski
et al., 2016) with the following modifications. DNA was isolated
from 30 to 50 mg of fresh leaf material harvested from individual
4 to 6-week-old M2 plants, using the BioSprint 96 system
(Qiagen, Hilden, Germany) according to the manufacturer’s
protocol. DNA was quantified fluorometrically using Hoechst
33258 dye and a plate reader (Fuoromax, United Kingdom).
DNA samples were normalized to 5 ng/µL using the Freedom
EVO R© 200 workstation (Tecan United Kingdom Ltd.) and
arranged in four-fold pools for reverse genetic screening. The
full-length genomic DNA sequence of the Artemis A. annua
CHI1 gene for TILLING was obtained by PCR using gene-
specific primers designed based on Gene Bank-deposited
sequence EZ246664. A 937-bp fragment of CHI1 was amplified
in a two-step PCR reaction. The first step was carried out with
unlabeled primers: 5′-TGGCAACACCACCTTCAGCTACC-
3′ (left) and 5′-CTGTGGTTGCTTTCTCATCAAAATGG-3′
(right) on 12.5 ng of pooled gDNA in 10 µL volumes. Nested
PCR and labeling with IR dyes were performed on a 1/10 dilution
of the first PCR with a mixture of unlabeled M13-tailed primers
(5′-TGTAAAACGACGGCCAGTCGACAGCAACTAGTAATGG
TAAACTG-3′ (left) and 5′-AGGAAACAGCTATGACCACAT
AAGATCTGAAAGTCTTGAAGCC-3′ (right), and with M13
left primer (5′-TGTAAAACGACGGCCAGT-3′) labeled with
IRDye700 and M13 right primer (5′-AGGAAACAGCTATGACC
AT-3′) labeled with IRDye 800 (MWG, Ebersberg, Germany).
Heteroduplex formation, CEL I nuclease digestion and analysis
on the LI-COR 4300 DNA sequencer platform were carried out
as previously described (Till et al., 2006). All mutants found on
the TILLING gels were verified by Sanger sequencing of both
DNA strands of PCR-amplified fragments using the following
primers: 5′-GCAATAATGCTATGTGTTGGTGC-3′ (left) and
5′-CACAATGTTTGCAGCTTCAGGTATG-3′ (right). Two
segregating M3 mutant populations were obtained by crossing
M2 siblings that were heterozygous for the chi1-1 mutation.
KASPTM SNP Assay for chi1-1 Mutation
Status
Twenty nanograms of DNA was used for 10 µL KASPar
assay reactions containing: 1 × KASP V4.0 low ROX master
mix (LGC Genomics); a concentration of 167 nM of each
of the two allele-specific primers: chi1-1_ForC: 5′-GAAG
GTGACCAAGTTCATGCTCAATGATACTACCATTAACTGGT
AAGC-3′ and chi1-1_ForT: 5′-GAAGGTCGGAGTCAACGGAT
TGACAATGATACTACCATTAACTGGTAAGT-3′ and 414 nM
universal primer chi1-1_Rev 5′-CTCCAACGCACATTTCAGA
CACCTT-3′, according to the manufacturer’s recommendations.
Allelic discrimination runs and allelic discrimination analysis
were performed on Viia7 system (Life Technologies Ltd.)
according to the manufacturer’s recommendations.
Metabolite Analysis by UPLC-and
GC-MS
Plants were grown from five cuttings from each genotype and
metabolic profiles were generated from 10 to 50 mg FW pooled
samples of leaves at different developmental stages: 4–6 (counting
from the apical meristem) representing the young stage; leaves
11–13 representing the mature, expanded stage and three leaves
taken just above first senescing leaves representing old leaves.
Fresh leaf samples were stored at −80◦C. Trichome-specific
metabolites were extracted as described previously (Czechowski
et al., 2016) and analyzed by UPLC-MS as previously described
(Graham et al., 2010; Czechowski et al., 2016). Dry leaf material
was obtained from 14-week-old plants, cut just above the zone
of senescing leaves and dried for 14 days at 40◦C. Leaves
were stripped from the plants, and leaf material sieved through
5 mm mesh to remove small stems. Metabolite extractions
from 10 mg of the dry leaf material and UPLC-MS analysis
were performed as previously described (Graham et al., 2010;
Czechowski et al., 2016). Number of the biological replicates
measured was as follows: young and mature wild-type leaves
n = 49, old wild-type leaves n = 60, dry wild-type leaves n = 21;
young-, mature- and old heterozygous chi1-1 leaves n = 94,
dry heterozygous chi1-1 leaves n = 37; young, mature and old
homozygous chi1-1 leaves n = 63, dry heterozygous chi1-1 leaves
n = 32. The experiments comparing trichome vs. whole-leaf
metabolites were performed on leaves 14–16 harvested from
five individuals grown from cuttings (n = 5). Trichome-specific
metabolites were first extracted from the fresh mature leaves
as described above. The remaining leaf material was washed
three times with 500 µL of chloroform and solvent removed by
pipetting. Leaf tissue was ground to a fine powder in TissueLyser
II (Qiagen, United Kingdom), extracted and quantified by UPLC-
MS. GC-MS analysis was performed on the same dipped and
ground-leaf extracts as described before (Czechowski et al.,
2016). To evaluate method suitability for detecting flavonoids,
comparative extracts of dry material were made with either 9:1
chloroform:ethanol (v/v; used throughout this study) vs. 85:15
methanol:water (v/v; typically used to extract polar flavonoids
from plant material). These extracts were then separated on an
extended UPLC gradient (starting conditions modified to 100%
of aqueous solvent A), to avoid any potentially highly polar
flavonoids being lost in the void volume.
Whole-Leaf Extraction for P. falciparum
Kill Rate Assays
Fourteen-week-old plants were cut above the area of senescing
leaves and dried for 14 days at 40◦C. Leaves were separated
from the rest of the dry plants and sieved through 5-mm
mesh to remove small stems. Dry leaves were stored long
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term in a humidity-controlled cabinet at 4◦C. For whole-leaf
extracts, 1 g dry leaves was ground to a fine powder and
extracted in 9:1 chloroform and ethanol solution overnight,
centrifuged at 4,700 rpm for 20 min and the supernatant was
filtered through Wattman paper. An aliquot was taken for
quantification by UPLC-MS. The solvent was evaporated until
only an oily residue remained and re-suspended in DMSO to
reach a final concentration of 5 mg/ml artemisinin (or to reach
a casticin concentration equivalent to that of the wild type in
the AMS RNAi line, or equivalent to heterozygous cyp71av1-1 in
homozygous cyp71av1-1).
In vitro Plasmodium falciparum Assays
The in vitro screening of antiplasmodial activity of extracts
was carried out starting with trophozoite stage (24–32 h post
infection) intraerythrocytic stages of the P. falciparum Dd2
strain using a 48 h (one complete cycle of intraerythrocytic
development) Malaria Sybr Green I Fluorescence assay as
previously described (Smilkstein et al., 2004; Ullah et al.,
2017). The mean percentage growth ± StDev (n = 9 from
three independent biological repeats) was plotted against log10-
transformed drug concentration and a non-linear regression
(sigmoidal concentration–response/variable slope equation) in
GraphPad Prism v5.0 (GraphPad Software, Inc., San Diego, CA,
United States) used to estimate the 50% effective concentration
(EC50) and the 95% confidence intervals.
Determination of the relative initial cytocidal activity against
trophozoite stage intraerythrocytic stages of the P. falciparum
Dd2luc (Wong et al., 2011) were carried out using the
Bioluminescence Relative Rate of Kill assay as described (Ullah
et al., 2017). All assays were carried out over 6 h using a
9× EC50 to 0.33× EC50 concentration series. The mean± StDev
bioluminescence signal, normalized to an untreated control, are
plotted (n = 9 from three biological repeats) and compared to the
benchmark standards of dihydroartemisinin (DHA), chloroquine
(CQ), mefloquine (MQ) and atovaquone (ATQ). Stock solutions
of atovaquone (10 mM in DMSO), chloroquine (100 mM in
deionized water), dihydroartemisinin (50 mM in methanol), and
mefloquine (50 mM in DMSO) were made (Sigma-Aldrich)
and stored at −20◦C. In all experiments, the maximum final
concentration of solvent was 0.6% (v/v).
RESULTS
Isolation and Characterisation of a CHI1
Mutant Impaired in Flavonoid
Biosynthesis
Casticin and other polymethoxylated flavonoids accumulate in
leaf and flower trichomes of the A. annua Artemis variety, some
to high levels comparable to those of artemisinin (Czechowski
et al., 2016, 2018). We previously identified three putative CHI
genes using A. annua transcriptome data (Graham et al., 2010).
CHI1 is expressed in young leaf and flower bud trichomes
whereas CHI2 is expressed in young and mature leaf trichomes
and CHI3 is expressed most highly in meristems and cotyledons
(Graham et al., 2010). Further quantitative RT-PCR-based
expression profiling, extended to other tissues, revealed thatCHI1
expression is the most trichome specific of the three genes tested,
whereas CHI2 is more generally expressed in several tissues and
CHI3 expression is not detected in trichomes (Figure 1A). The
229 amino acid-long predicted protein sequence for CHI1 is most
similar to CHI characterized in other organisms than it is to the
other two putative CHI proteins we previously identified from
A. annua (Supplementary Figure S1A; Jez et al., 2000). Amino
acid sequence alignment of CHI homologs shows that CHI2
and CHI3 are missing a number of highly conserved residues
including those required for substrate binding (Supplementary
Figure S1A; Jez et al., 2000). In contrast CHI1 contains all of
the conserved residues, suggesting that it is the only one of the
three CHI homologs from A. annua that produces a functional
chalcone isomerase enzyme.
Using an established ethyl methanesulfonate-mutagenized
population of A. annua (Czechowski et al., 2016) we performed
a TILLING screen of the single-copy CHI1 gene that resulted
in an allelic series of five mutants, including three with
intronic mutations, one with a silent mutation and one with
a nonsense mutation that created a C1567 to T transition
in the third exon of CHI1 (Figure 1B and Supplementary
Figure S1B). The latter mutation, which we designate chi1-1,
gave a predicted change of amino acid Gln107 in the polypeptide
to a stop codon that would result in a major truncation
of the enzyme and loss of most of the putative substrate-
binding site (Figure 1C and Supplementary Figure S1A).
CHI is a functional monomer and residues that are important
for substrate binding and the active site in other species lie
beyond the residue corresponding to A. annua CHI1 Q107
(Figure 1C and Supplementary Figure S1A; Jez et al., 2000),
FIGURE 1 | Discovery and characterization of the chi1-1 mutation.
(A) Artemisia annua CHI1, CHI2 and CHI3 expression in meristems,
cotyledons, young leaf trichomes, young leaves, fully expanded leaves,
mature leaves, stems, flowers, and no template control (NTC) were
determined by semi-quantitative PCR. UBQ (Putative ubiquitin-like protein,
GQ901904) was used as a loading control. (B) Gene schematic of CHI1
indicates the position of the chi1-1 mutation. (C) The A. annua CHI1 protein
structure was modeled by I-TASSER (Yang et al., 2015) on the 10 most
closely related structural analogs. The parts of the structure expected to be
missing in the chi1-1 mutant are highlighted in yellow, naringenin (enzyme
product) bound to CHI1 is shown in blue.
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which suggested the truncation would result in a complete loss
of CHI function.
In order to investigate the effects of the chi1-1 mutation on
artemisinin and flavonoid biosynthesis we analyzed three leaf
developmental stages: young (leaves 4–6 as counted down from
the apical meristem), mature (leaves 11–13) and old (3 leaves
preceding the first senescing leaves). To generate material for
this analysis we performed two crosses of heterozygous chi1-
1 M2 siblings originating from a self-fertilized M1 individual
and performed DNA marker-based selection of wild type (WT)
and heterozygous and homozygous chi1-1 individuals from the
segregating M3 population using the KASPTM SNP assay. We
observed a strong segregation distortion from the expected
1:2:1 (WT:heterozygous:homozygous mutation) in both M3
populations. The first cross resulted in 30 individuals of which
24 were heterozygous and 6 homozygous for the chi1-1 mutation
whereas the second cross resulted in 54 individuals of which 36
were heterozygous and 18 homozygous for the chi1-1 mutation,
but we could not identify segregating wild-type individuals.
Such segregation distortion is not unusual for A. annua, which
naturally outcrosses, and has been reported for the populations
coming from self-fertilized individuals (Graham et al., 2010). In
the absence of any segregating M3 wild–type individuals we used
non-mutagenized Artemis F1 as wild type for metabolic profiling.
CHI disruption or suppression has previously been reported
to result in discoloration and/or decreased flavonol levels in
Arabidopsis thaliana, petunia, carnation, onion and tobacco (van
Tunen et al., 1991; Shirley et al., 1992; Itoh et al., 2002; Kim et al.,
2004; Nishihara et al., 2005) whereas petunia CHI overexpression
leads to increased flavonol accumulation in tomato (Muir et al.,
2001). A. annua produces the polymethoxylated flavonoids
casticin, artemetin, chrysoplenetin, chrysosplenol-D, and
cirsilineol (Bhakuni et al., 2001). Whereas the wild type and
the chi1-1 heterozygote produced similar amounts of casticin,
chrysoplenol C, dehydroxycasticin and artemetin none of these
flavonoids were detectable in homozygous chi1-1 individuals
(Figures 2Ai–iv). These results demonstrate that chi1-1 is a null
allele. Flavonoids in the wild type and heterozygous chi1-1 are
most abundant in young, followed by mature and old leaves
(Figure 2A). Noteworthy, chi1-1 accumulated a compound with
an m/z ratio of 273.0757 that was not detectable in the wild type
or the chi1-1 heterozygote (Figure 2Av). The UPLC-MS profile
of this compound suggests it represents the molecular ion of
naringenin chalcone (MW = 272.26 g/mol), the substrate of
chalcone isomerase, which would be expected to accumulate in
the chi1-1 null mutant.
We initially devised our chloroform:ethanol extraction
method to be optimal for artemisinin extraction, which has
a logP of 2.8. Chloroform has a logP value of ∼2.3, which
is also quite closely matched to the calculated logP values of
A. annua methoxylated flavonoids (2.1–3.4, using structures
reported by Ferreira et al., 2010). We compared our 9:1
chloroform:ethanol extraction method used throughout this
study with a solvent more typically used for flavonoid extraction
(85:15 methanol:water) by extracting WT and homozygous
chi1-1 dry material (Supplementary Table S4). The UPLC
method was also extended so that the elution conditions at the
start of the run were much more aqueous, to ensure that any
polar flavonoids (if present) were not eluted in the void volume.
Peaks were picked and identified according to our standard high-
resolution accurate mass protocols, and additionally matched
against formula hits for 40 previously reported flavone and
flavonol compounds from A. annua (Ferreira et al., 2010). The
results show, from dry material, that 142 peaks could be resolved
of which only six potential flavonoids could be identified; all six
of these compounds were extracted in both solvent systems, and
were in fact best extracted in our standard chloroform:ethanol
solvent (Supplementary Table S4). As expected, highly polar
phenolic compounds such as scopolin and scopoletin (PubChem
xlogP values of −1.1 and 1.5, respectively) extracted better in
the methanolic solvent and could be resolved using the adapted
UPLC method. All 40 flavonoids reported by Ferreira et al. (2010)
have predicted xlogP values in the range −1.3–3.5, so we would
expect to detect these in the modified UPLC method, if present
in any of the extracts. From this comparison we conclude that
our chloroform:ethanol extraction solvent is sufficient to extract
the full suite of flavonoids present in the various A. annua
genotypes used in the present study, which all derive from the F1
Artemis commercial variety (Delabays et al., 2001) which serves
as the wild type in the current study. In a detailed metabolite
analysis of high- and low- artemisinin-producing chemotypes of
A. annua, which involved both MS and NMR based detection
and identification we found similarly low numbers of flavonoids
(Czechowski et al., 2018). We note that the much larger number
of flavonoids reported in the review by Ferreira et al. (2010)
are based to an extent on HPLC-UV analysis of A. annua
material obtained from Yunnan Herbarium, China (Lai et al.,
2007). Future work involving comparative metabolite analysis of
different cultivars grown under identical conditions should help
establish the basis of the difference in the numbers of flavonoids
being reported in these different studies.
Finally, artemisinin levels were consistently decreased in all
homozygous chi1-1 leaf material types compared to heterozygous
chi1-1 and the wild type (Figure 2Avi). DHAA levels were
simultaneously reduced in young leaves of homozygous chi1-1
when compared to heterozygous chi1-1 and the wild type
(Supplementary Table S1). We also observed a mild reduction in
the level of dihydroartemisinic acid tertiary allylic hydroperoxide
in all leaf types of homozygous chi1-1 when compared to
heterozygous chi1-1 and the wild type. On the other hand,
levels of DHAA-derived 11,13-dihydroamorphanes such as
dihydro-epi-deoxy arteannuin B, deoxyartemisinin, arteannuin
I/J, arteannuin M/O and 11-hydroxy-arteannuin remained
unchanged in homozygous chi1-1 (Supplementary Table S1).
To further confirm the specificity of the effects of the
chi1-1 mutation on trichomes, we analyzed metabolites in
trichomes and leaves separately. Fresh mature leaves were
dipped in chloroform to disrupt the trichomes and release the
contents (dip), as previously described (Graham et al., 2010),
and the remaining leaf material was ground, extracted and
analyzed separately (ground leaves). Known trichome-specific
compounds such as artemisinin, DHAA or camphor were found
in extracts from the dip treatment but not in the post-dip ground
leaf extracts (Figures 2Bi,iii and Supplementary Table S2),
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FIGURE 2 | Effects of the chi1-1 mutation on the metabolite profile of Artemisia annua. Box and whisker plots showing levels of (A) four major flavonoids, putative
naringenin chalcone and artemisinin as measured by UPLC-MS in young (leaves 1–5 as counted from the apical meristem), mature (leaves 11–13), old (three leaves
above first senescing leaf) and dry (oven-dried) leaf material harvested from 12 to 14-week-old plants of the Artemis wild type (black), heterozygous (blue) and
homozygous chi1-1 mutant (red) and (B) selected flavonoids, sesquiterpenes and monoterpenes in the extracts from dipped (dip) or ground leaf material for the wild
type (black) and heterozygous (blue) and homozygous (red) chi1-1 mutant. Metabolite concentrations measured by GC- or UPLC-MS (A,B) are expressed as a
proportion of the residual dry leaf material following extraction. Groups not sharing letters representing Tukey’s range test results indicate statistically significant
differences (p < 0.05). Each box is represented by minimum of 20 (A) or by five (B) biological replicates. (C,D) Principal component analysis of 83 UPLC-MS
identified peaks (C) and of 58 GC-MS identified peaks (D) from dipped and ground leaf material from wild type (black) and heterozygous (blue) and homozygous
chi1-1 (red). Dip leaf extracts are represented by circles and ground leaf extracts by triangles. Principal component analysis was performed on log-scaled and
mean-centered data.
consistent with previous morphological studies (Duke
et al., 1994) and the trichome-specific expression of the
relevant biosynthetic pathway enzymes (Olsson et al., 2009;
Graham et al., 2010; Olofsson et al., 2011; Soetaert et al., 2013).
Casticin, chrysoplenol C/D, dehydroxycasticin and artemetin
were also found in extracts from dip treatments but not in
post-dip ground leaf extracts from heterozygous chi1-1 or
the wild type, but were completely absent in homozygous
chi1-1 dip and post-dip ground leaf extracts (Figure 2Bii
and Supplementary Table S2). β-farnesene, germacrene-D,
trans-caryophyllene and squalene were found mostly in post-
dip ground leaf extracts (Figure 2Biv and Supplementary
Tables S2, S3). This is consistent with the previous metabolite
studies on gland bearing vs. glandless biotypes of A. annua
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TABLE 1 | Artemisinin and flavonoid levels and antimalarial efficacy of plant extracts.
Artemisinin
(mg/mL)
Casticin
(mg/mL)
Dehydroxycasticin
(mg/mL)
Cirsilineol
(mg/mL)
Chrysoplenol C
(mg/mL)
Artemetin
(mg/mL)
Total detected
flavonoid
(mg/mL)
EC50 (ng/mL)
[95% CI]
Wild type 5.00 ± 0.80b 0.51 ± 0.07c 0.09 ± 0.01c 0.11 ± 0.04b 0.004 ± 0.003a 0.00a 0.71 ± 0.12c 15.6 [14.5–16.8]
chi1-1 het 5.00 ± 0.28b 0.36 ± 0.02b 0.042 ± 0.009b 0.00a 0.005 ± 0.002a 0.00a 0.40 ± 0.03b 34.6 [31.7–37.9]
chi1-1 hom 5.00 ± 0.44b 0.00a 0.00a 0.00a 0.00a 0.00a 0.00a 25.7 [25.1–26.4]
AMS silenced line 0.062 ± 0.007a 0.50 ± 0.06c 0.021 ± 0.007ab 0.006 ± 0.002a 0.00a 0.12 ± 0.01c 0.65 ± 0.08c 350.4 [303.1–405.1]
cyp71av1-1 het 5.00 ± 0.55b 0.69 ± 0.04d 0.15 ± 0.02d 0.00a 0.074 ± 0.012b 0.00a 0.91 ± 0.05d 14.1 [13.5–14.7]
cyp71av1-1 hom 0.00a 0.61 ± 0.14cd 0.31 ± 0.05e 0.00a 0.00a 0.08 ± 0.01b 1.00 ± 0.19d 4220 [3820–4665]
Mean concentrations and standard deviations from the mean of five technical replicates are shown. Total detected flavonoid is the sum of the five listed flavonoids. Letters
represent Tukey’s range test results after one way ANOVA for each metabolite or total detected flavonoids. Genotypes not sharing letters indicate statistically significant
differences (p < 0.05). EC50 is the 50% effective concentration of extract needed to inhibit growth of the Plasmodium falciparum parasites. Artemisinin concentrations
have been normalized to 5 mg/ml in wild type, chi1-1 het, chi1-1 hom and cyp71av1-1 as detailed in section “Whole-Leaf Extraction for P. falciparum Kill Rate Assays.”
(Tellez et al., 1999) and with the ubiquitous expression of the
relevant terpene synthases in A. annua (Graham et al., 2010;
Olofsson et al., 2011). A principal component analysis for 83 of
the UPLC-MS (Figure 2C) and 58 of the GC-MS (Figure 2D)
detectable metabolites revealed that homozygous chi1-1 more
strongly diverged from the wild type and heterozygous chi1-1
in extracts from dip treatment, but less so in post-dip ground
leaf extracts, where ground material clustered together. These
findings suggested that the chi1-1 mutant is mainly disrupted
in trichome metabolism and that CHI1 is needed for flavonoid
synthesis specifically in trichomes.
Flavonoids Do Not Contribute
Antimalarial Activity in Whole-Leaf
Extracts
The chi1-1 line allowed for a direct comparison of A. annua
extracts with and without flavonoids to evaluate the contribution
of the cytocidal effects of these compounds on Plasmodium
parasites in vitro. To evaluate whether there were changes
from the potent and rapid cytocidal effects expected from
artemisinin-containing extracts, the metabolites from wild
type, and heterozygous and homozygous chi1-1 extracts
were quantified and re-suspended to the same artemisinin
concentration (Table 1). The antiplasmodial activity against
asexual intraerythrocytic stages of P. falciparum indicated
that the effective concentration required to inhibit growth
by 50% (EC50) was essentially the same, between 15 and
35 ng/ml for the wild type and heterozygous and homozygous
chi1-1 (Figure 3A and Table 1). We also performed an
evaluation of the initial cytocidal activity of the same extracts
using a Bioluminescence Relative Rate of Kill (BRRoK) assay
(Ullah et al., 2017). Here, asexual intraerythrocytic stages of
P. falciparum are exposed to multiples (0.33 to 9X) of EC50 of
extract, or benchmark antimalarial drugs of a known order of
rate of kill, for 6 h. This assay allows a compound/extract to be
compared to fast cytocidal drugs like artemisinin, the derivative
dihydroartemisinin and chloroquine; slower cytocidal drugs
like mefloquine; and cytostatic drugs such as atovaquone (Ullah
et al., 2017). When performing BRRoK assays, the three samples
were indistinguishable from one another and most similar
to dihydroartemisinin (the active metabolite of artemisinin
compounds) in the concentration v. loss of bioluminescence
plot (Figure 3B). These results indicate that flavonoids in the
wild-type extracts did not alter the fast cytocidal activity of
artemisinin in the samples.
Artemisinin-Reduced Whole-Leaf
Extracts Lack Potent and Rapid
Antiplasmodial Activity
To test for the potential antiplasmodial activity of artemisinin-
unrelated compounds in A. annua, we used the artemisinin-
reduced AMS silenced plant line (Catania et al., 2018).
Samples from this line were prepared alongside the other genetic
variants and re-suspended to match the wild-type casticin levels,
which resulted in a 100-fold reduction in artemisinin levels
compared to the wild type (Table 1). Determination of the
EC50 in the AMS silenced line revealed a greater than 20-
fold reduction in potency when compared to the wild-type
(Figure 3A). Moreover, samples from the AMS silenced line in
the BRRoK assay lacked the rapid initial cytocidal activity of
the wild type and heterozygous and homozygous chi1-1 samples
and were only apparently cytocidal at concentrations above
3xEC50 (Figure 3B).
We also used a cyp71av1-1 mutant shown to be completely
deficient in the synthesis of artemisinin (Czechowski et al., 2016)
to investigate potential antiplasmodial effects of flavonoids (and
other A. annua compounds) in the absence of artemisinin. As
a control we used heterozygote cyp71av1-1 that accumulates
wild-type artemisinin levels. In extracts from cyp71av1-1
antiplasmodial activity was reduced ∼300 fold compared to
extracts from heterozygous cyp71av1-1 (Figure 3C). The initial
cytocidal activity of the control heterozygote cyp71av1-1 extracts
were comparable to those of the wild type and chi1-1 extracts,
whereas cytocidal activity was reduced in the cyp71av1-1
mutant (Figure 3D). It is noteworthy that extracts from
cyp71av1-1 homozygous lines are among the highest in total
flavonoid content of the material used for anti-plasmodial assays
(Table 1). Taken together these results represent convincing
evidence that A. annua flavonoids do not exhibit anti-plasmodial
activity in in vitro assays. These results also suggest that the
sesquiterpene epoxide artennuin X, one of the most abundant
metabolites produced by cyp71av1-1 in the absence of artemisinin
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FIGURE 3 | Comparison of in vitro antiplasmodial activity of leaf extracts from Artemisia annua wild type, mutant and antisense lines with altered flavonoid and
artemisinin content. (A,C) Log concentration-normalized response curves of Plasmodium falciparum parasites after 48 h of treatment with extracts used to
determine the EC50 (50% effective concentration of extract needed to inhibit growth of the P. falciparum parasites) of the indicated extracts. (B,D) Bioluminescent
Relative Rate of Kill (BRRoK) assays to determine the initial (6 h) cytocidal action, compared to an untreated control after exposure to extracts of wild type,
heterozygous and homozygous chi1-1, and the AMS silenced line (B) or heterozygous and homozygous cyp71av1-1 (D) at multiples of the EC50 alongside
dihydroartemisinin (DHA) > chloroquine (CQ) > mefloquine (MQ) > atovaquone (ATQ) benchmark controls. Error bars represent standard deviations from the means
of three biological replicates.
(Czechowski et al., 2016), also does not have appreciable
antiplasmodial activity. This is not really surprising as arteannuin
X does not carry an endoperoxide bridge (Czechowski et al.,
2016), which is thought to be crucial for antiplasmodial activity
of sesquiterpene lactones such as artemisinin.
DISCUSSION
CHI1 Is Necessary for Trichome-Specific
Flavonoid Synthesis
We report the identification and characterization of an A. annua
mutant in CHI1, which encodes the enzyme that catalyzes the
second committed step of the flavonoid biosynthesis pathway.
The chi1-1 mutation is predicted to result in a truncation
that would preclude a sizable portion of the CHI1 functional
monomer, including sections that may interact with the product
naringenin (Figure 1C and Supplementary Figure S1A). Indeed,
chi1-1 failed to produce all four major polymethoxylated
flavonoids, usually detected in young, mature and dry A. annua
leaves (Figures 2Ai–iv). Flavonoid levels in heterozygous chi1-1
were comparable with wild type (Artemis), which indicates
that chi1-1 is a recessive mutation (Figures 2Ai–iv). Expression
profiling in various tissues of wild-type A. annua demonstrated
that CHI1 seems to be specifically expressed in trichomes
(Figure 1A). In fact, we showed that the effect of the chi1-
1 mutation on metabolite levels is clearly trichome-specific
(Figures 2B–D and Supplementary Table S2) which is consistent
with the CHI1 expression pattern (Figure 1A). The fact that two
other CHI gene homologs expressed in A. annua (CHI2 and
CHI3) did not compensate for the lack of flavonoids in trichomes
of chi1-1 strongly suggests that CHI1 is the main enzyme
responsible for flavonoid biosynthesis in A. annua trichomes.
The precursors of all secondary or specialized metabolites
in higher plants are derived from primary metabolism.
Phenylpropanoid biosynthesis leading to flavonoids relies on the
synthesis of L-phenylalanine from chorismate, sourcing carbon
precursors from the pentose phosphate pathway of primary
metabolism. Terpenoid biosynthesis on the other hand starts
from the common precursors supplied by the plastidic MEP and
the cytosolic mevalonate pathways, which both rely on carbon
sourced from glycolysis. Crosstalk between the phenylpropanoid
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and terpenoid biosynthetic pathways occurs, therefore, at the
level of early carbon precursors, such as glyceraldehyde 3-
phosphate and acetyl-CoA, and with reducing power provided
by NAD(P)H and energy released from ATP hydrolysis. We
had therefore speculated that artemisinin biosynthesis may be
improved by specific blockage of flavonoid biosynthesis in
A. annua trichomes, due to more carbon precursors becoming
available for farnesyl pyrophosphate biosynthesis. However, we
did not observe any increase in levels of artemisinin or related
precursors in homozygous chi1-1 mutants disrupted in flavonoid
production (Figures 2Aiv,Bi). On the contrary, artemisinin levels
in all chi1-1 leaf ages were lower when compared to heterozygous
chi1-1 and the wild type (Figures 2Aiv,Bi). The reduction of
artemisinin levels in chi1-1 might be explained by lower DHAA
levels (Supplementary Table S1), which could be due to either
decreased DHAA synthesis or enhanced DHAA degradation,
but the connection to the chi1-1 mutation is unclear. The
crosstalk between phenylpropanoid and terpenoid metabolism
is further highlighted by the report that overexpression of the
A. annua CINNAMYL ALCOHOL DEHYDROGENASE results in
an increase in lignin and coumarin and a reduction in artemisinin
and other sesquiterpenes (Ma et al., 2018).
Flavonoids Had No Effect on the in vitro
Antiplasmodial Activity of A. annua
Extracts
Flavonoids have been suggested as candidates for increasing
antiplasmodial activity and potentially slowing the emergence
of resistance in whole-plant preparations, relative to artemisinin
alone (Weathers et al., 2014; Elfawal et al., 2015). It has been
proposed that these attributes may arise due to flavonoids
enhancing artemisinin action by increasing artemisinin solubility
in water (Mueller et al., 2000) or through the action of some
flavonoids, such as casticin, in increasing artemisinin binding
to hemin, one potential target of artemisinin action (Bilia et al.,
2002). Artemisinin action in vitro against intraerythrocytic stages
of P. falciparum typically provides an EC50 of 3–5 nM (Liu
et al., 1992; Hasenkamp et al., 2013). Casticin, the most abundant
flavonoid in A. annua, has an EC50 of 65 µM and 5 µM casticin
reduced the artemisinin EC50 some 3–5 fold (Liu et al., 1992).
Artemetin also reduces the artemisinin EC50, although to a lesser
degree than casticin (Elford et al., 1987). In another report,
the flavonoids artemetin, casticin, chrysoplenetin, chrysosplenol-
D, cirsilineol and eupatorin have an IC50 that is 100 times
that of artemisinin (Liu et al., 1992). When combining 5 µM
of these flavonoids with artemisinin, the artemisinin IC50 is
reduced to as much as half (Liu et al., 1992). However, the
interactive mode of action of these compounds is unclear. In
an isobologram analysis of compound interactions, casticin has
an antagonistic antimalarial activity with artemisinin in a 3:1
combination (Suberu et al., 2013) but is apparently synergistic at
a 10–10,000:1 combination (Elford et al., 1987; Liu et al., 1992).
Therefore, additional compounds in whole-plant preparations
could have synergistic or antagonistic effects with artemisinin
depending on the relative concentration in the plant. Results
of our in vitro antiplasmodial activity assays using Artemisia
whole-leaf preparations do not show any synergistic effects
between flavonoids and artemisinin, in contrast to previous
reports (Ferreira et al., 2010; Suberu et al., 2013). We observed
no appreciable differences between the artemisinin-producing
heterozygous chi1-1 (flavonoid containing) and homozygous
chi1-1 (flavonoid lacking) in terms of their EC50 potency or initial
rate of cytocidal activity (Figure 3B). We therefore conclude
that flavonoids do not appreciably contribute to the in vitro
antiplasmodial activity beyond that provided by the artemisinin
content, at least in the concentrations at which they are present
in leaves of Artemis, a commercial F1 hybrid of A. annua
(Delabays et al., 2001).
The in vitro Antimalarial Activity of
A. annua Extracts Is Predominantly Due
to Artemisinin
Several groups have investigated compounds in A. annua
extracts to find new sources of antimalarial activities other than
artemisinin, or explore the possibility that A. annua compounds
aid artemisinin (O’Neill et al., 1985; Elford et al., 1987; Liu et al.,
1989, 1992; Mueller et al., 2000; Bhakuni et al., 2001). A. annua
compounds having antimalarial activity have been reported
but with EC50 values that are over three orders of magnitude
higher than artemisinin (Suberu et al., 2013). In in vitro assays,
arteannuin B and artemisinic acid have been shown to have
additive antimalarial activity with artemisinin, whereas DHAA
has antagonistic antimalarial activity with artemisinin (Suberu
et al., 2013). Furthermore, some artemisinin precursors isolated
from A. annua tea, including 9-epi-artemisinin and artemisitene,
while being reported to have antimalarial activity themselves,
can act antagonistically with artemisinin, possibly because they
could have similar molecular targets in the malarial parasite
(Suberu et al., 2013). However, artemisinin related compounds
reported to either act by themselves or aid artemisinin are
present in A. annua at much lower concentrations than
required for antimalarial activity based on the EC50 (Elford
et al., 1987; Bhakuni et al., 2001; Suberu et al., 2013), and
therefore would perhaps not be expected to have an effect in
whole-leaf extracts.
Our data suggests that the artemisinin-reduced extracts
prepared so that they have wild-type casticin levels (Table 1),
and likely the same concentration of non-artemisinin related
compounds as wild-type extracts, had no in vitro antiplasmodial
activity beyond that provided by the residual artemisinin in the
homozygous chi1-1 extracts (Figures 3A,B). We extended our
studies to include the use of cyp71av1-1 mutant extracts, which
has been shown to completely lack artemisinin (Czechowski
et al., 2016). Whereas the cyp71av1-1 heterozygote control extract
was essentially indistinguishable from those of the wild type
and the chi1-1 homozygote (Figures 3C,D), extracts of the
cyp71av1-1 homozygote were some 350–1000 fold less potent in
their antiplasmodial activity. Whilst the cyp71av1-1 homozygote
did demonstrate a moderate to good initial cytocidal activity
(Figure 3D), the BRRoK assay of these extracts used at least 10
times a greater concentration of extract than any other sample by
virtue of these assays using multiples of the EC50.
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While our results clearly demonstrate that flavonoids from
A. annua plant extracts do not play a role in enhancing
antiplasmodial activity relative to artemisinin in in vitro assays,
the possibility remains that these compounds could have in
vivo effects (Elfawal et al., 2012, 2015). It has been postulated
that flavonoids could increase artemisinin solubility or inhibit
activity of the cytochrome P450s responsible for degradation
of artemisinin (Elfawal et al., 2012). A. annua extracts have
been shown to result in higher artemisinin concentration
in mice blood than the same concentration of artemisinin
alone and this effect was attributed to arteannuin B (Cai
et al., 2017). However, it should be noted that artemisinin
is known to dissolve poorly in water and has a short serum
half-life (Elfawal et al., 2012). Consequently, artemisinin
is typically chemically converted to dihydroartemisinin,
artesunate or artemether to improve solubility and increase
its half-life in human serum (Petersen et al., 2011). These
improved artemisinin-based compounds are combined with a
companion drug from a different class to formulate ACTs - the
WHO recommended method of treatment for patients with
malaria. Companion drugs include lumefantrine, mefloquine,
amodiaquine, sulfadoxine/pyrimethamine, piperaquine and
chlorproguanil/dapsone. This combination contributes to
high efficacy, fast action and reduction in the likelihood
of resistance developing for ACTs. In vivo investigations
into the effectiveness of whole plant extracts for the
treatment of malaria should use approved artemisinin-
related compounds with improved solubility and lifetime
in human serum or indeed ACTs, rather than artemisinin
alone, as a proper comparator in studies to investigate
the potential of whole-leaf extracts from A. annua. We
conclude that endogenous flavonoids present in whole-leaf
extracts of A. annua have no appreciable effect on the
antimalarial activity of artemisinin as determined by quantitative
in vitro assays.
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